EN DE
Watch Labixiaoxin Snacks Group Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Labixiaoxin Snacks Group Ltd (1262) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Labixiaoxin Snacks Group Ltd stock HK$1.22, price HK$4.29, that is 71.6% below the price, quality 42 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive HK · Based in China · ISIN BMG5546K1080

LS Labixiaoxin Snacks Group Ltd logo Thin data Nov 14, 2026

Labixiaoxin Snacks Group Ltd

1262 · HK

Far too expensive (fair value 72% below the price) and weak company, but rising price: meets 1 of 3 rules.

Get notified free when this changes
Rising price (uptrend) 
Low debt 
Revenue last quarter +22% vs. a year ago. 
Quality 42/100 
Expensive Growth (revenue 5y +13.8 %/yr in CNY) 
Loss over the last twelve months · -0.8% net margin (TTM) · fiscal year 2025 1.2% 
Changed on Oct 23: HK$1.06 → HK$1.22 
Fair value HK$1.22 · Strongly overvalued 
Negative free cash flow 
Trails peers (3/11) 
Narrow moat 18/100 · thin data
Thin data 
Watch Labixiaoxin Snacks Group Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$5.50 HK$1.05 Fair Value HK$1.22 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range HK$1.05 – HK$5.50 · fair‑value band HK$0.9200 – HK$1.53 · the HK$4.29 price screens above the HK$1.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 14, 2026.

Follow Labixiaoxin Snacks Group in your weekly email

Every Wednesday you see whether Labixiaoxin Snacks Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Labixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China.

Show moreShow less

It offers jelly snacks, such as fruit-flavored, canned fruit, yogurt, and mousse jellies; jelly beverages; lollipops, milk and gummy candies, and chocolates; fruit and vegetable beverages; and powdered milk tea, dried bean curd, and baked products under the Labixiaoxin, Sunshine City, Humor, and Xiangdoufang brands.

The company was formerly known as China Lifestyle Food and Beverages Group Limited and changed its name to Labixiaoxin Snacks Group Limited in June 2012. Labixiaoxin Snacks Group Limited was founded in 2000 and is headquartered in Jinjiang, the People's Republic of China.

Stock analysis

Labixiaoxin Snacks Group Ltd (1262) currently trades at HK$4.29, while our model-based Fair Value estimate is HK$1.22, 72% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of HK$1.22 per share, and 0 of the 13 models we run sit above the HK$4.29 price.

Bear case: the Asset-Based group reads lowest at HK$0.4800, and 13 of the 13 models stay below the price. Data coverage for this calculation is low.

Scenario range: HK$0.9200 (bear) to HK$1.53 (bull), the price of HK$4.29 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Labixiaoxin Snacks Group Ltd reported revenue of 970M CNY in FY2025 versus 648M CNY in FY2021, a compound +10.6%/yr. Reported net income was 11.9M CNY in FY2025.

Key figures

Market cap HK$982M (≈ $125M) Micro · P/S ratio 0.93 · Net margin −0.8% · Return on equity −3.2% · Return on assets (EBIT) −3.3% (5-year average) · Operating margin −0.9% · Revenue (TTM) 1.1B CNY · Revenue growth (YoY) +21.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 18 out of 100 (low confidence).

What moves the price

The share trades about 7% below its 52-week high and 172% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 3% fair-value upside, at −72%, 1262 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (HK$0.3500 to HK$3.91). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear HK$0.9200 Fair Value HK$1.22 Bull HK$1.53
Price HK$4.29 · Downside -71.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV HK$1.39 HK$1.52 HK$1.63 74
ROIC Compounder HK$1.43 HK$1.63 HK$1.84 72
Residual Income HK$0.7900 HK$0.7700 HK$0.8000 71
All 14 models by family
Earnings-Based
Graham-Dodd HK$0.4000 HK$1.17 HK$1.54 65
Lynch FV HK$0.2400 HK$0.3500 HK$0.4500 61
PEG = 1.0 HK$0.2400 HK$0.3500 HK$0.4500 57
EPV HK$1.39 HK$1.52 HK$1.63 74
Multiples
P/E Multiple HK$0.9200 HK$1.22 HK$1.53 63
P/S Multiple HK$0.7400 HK$0.9900 HK$1.24 58
P/B Multiple HK$2.93 HK$3.91 HK$4.89 55
EV/EBIT n/a HK$0.3500 HK$0.9900 61
EV/EBITDA HK$0.7000 HK$1.66 HK$2.63 63
EV/Revenue n/a n/a HK$0.3400 50
Asset-Based
NCAV (Graham) HK$0.3600 HK$0.4800 HK$0.7100 54
Economic Profit
Residual Income HK$0.7900 HK$0.7700 HK$0.8000 71
ROIC Compounder HK$1.43 HK$1.63 HK$1.84 72
Growth Earnings
Growth-Adj P/E HK$0.7400 HK$1.06 HK$1.38 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 42/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 42
How much profit the company makes from its sales and capital
Quality Growth 74
Are margins and returns getting better?
Cashflow 31
Do the profits arrive as real cash?
Financial strength 22
Debt, balance sheet and risk of trouble
Investment 88
Does it invest with discipline instead of growing at any price?
Low Volatility 48
How calm the share price moves, does not count
Price momentum 95
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 95
Distance to the 52-week high, does not count
New shares 16
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+11.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.8%
Start year 2020 (pandemic). Over 10 years: −0.8% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
10.9% (2020) → 3.1% (2025)

1262 screens overvalued: fair value 72% below the price. Compare with Nestlé S.A →

Compare Labixiaoxin Snacks Group Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 662 stocks

Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 42 · Bottom 25%
Fair Value upside −71.6% · Bottom 25%
Profitability
Return on assets 1.4% · Below median
Net margin (12 months) −0.8% · Bottom 25%
Operating margin (12 months) −0.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 21.8% · Top 25%

Valuation Multiplesvs Packaged Foods median · lower = cheaper

P/B 3.68× · Priciest 25%
P/S (12 months) 0.77× · Cheaper than median
EV/EBITDA 17.1× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 34
FUTURE (revenue growth)100 · sector 25
PAST (return on equity)0 · sector 30
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)0 · sector 55

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wilmar International Limited F34 2.94 SGD 4.94 SGD +68% vs 1262
Inner Mongolia Yili Industrial Group 600887 ¥31.74 ¥41.84 +32% vs 1262
The Kraft Heinz Company KHC $25.11 $29.20 +16% vs 1262
Foshan Haitian Flavouring and Food Company 603288 ¥34.89 ¥38.07 +9% vs 1262
General Mills, Inc GIS $34.32 $35.30 +3% vs 1262
Danone S.A BN €69.80 €50.65 −27% vs 1262
Nestlé S.A NESN CHF 87.72 CHF 59.51 −32% vs 1262
Kerry Group KRZ €101.70 €60.33 −41% vs 1262
Nestlé India Limited NESTLEIND ₹1,263 ₹724.74 −43% vs 1262
Yihai Kerry Arawana Holdings 300999 ¥25.27 ¥12.21 −52% vs 1262

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Labixiaoxin Snacks Group Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Labixiaoxin Snacks Group Ltd Fair Value". https://www.fairvalue-calculator.com/stock/1262

Frequently asked questions

Is Labixiaoxin Snacks Group Ltd (1262) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of HK$1.22 versus a price of HK$4.29, about 72% lower (overvalued).
What is the fair value of 1262?
Our model-based fair value for Labixiaoxin Snacks Group Ltd is HK$1.22 (as of Nov 14, 2026), built from audited fundamentals. The current price: HK$4.29.
What is the quality score of 1262?
Labixiaoxin Snacks Group Ltd has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Labixiaoxin Snacks Group Ltd (1262)?
Our model-based price target is the fair value of HK$1.22 (as of Nov 14, 2026) from 14 valuation models. Cautious scenario HK$0.9200, optimistic scenario HK$1.53. It is a calculation from audited fundamentals, not an analyst target.
What is the Labixiaoxin Snacks Group Ltd stock forecast for 2026?
Our models put fair value at HK$1.22, about 72% lower versus a price of HK$4.29 (overvalued). Cautious scenario HK$0.9200, optimistic scenario HK$1.53. The calculation is refreshed regularly with new filings.
What is the revenue of Labixiaoxin Snacks Group Ltd (1262)?
Labixiaoxin Snacks Group Ltd reported trailing-twelve-month revenue of about 1.1B CNY (latest available figure, as of Nov 14, 2026).
What is the intrinsic value of Labixiaoxin Snacks Group Ltd (1262)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Labixiaoxin Snacks Group Ltd it is HK$1.22 per share (as of Nov 14, 2026), against a price of HK$4.29. It is the blended result of 14 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Labixiaoxin Snacks Group Ltd stock overvalued or undervalued in 2026?
As of Nov 14, 2026, 1262 trades above its calculated fair value: price HK$4.29, fair value HK$1.22, a gap of about −72% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 1262?
No. The price is what the market pays today (HK$4.29); the fair value is what the company's own numbers justify (HK$1.22). For Labixiaoxin Snacks Group Ltd the two are HK$3.07 per share apart. That gap is exactly why we show both numbers side by side.
How much is Labixiaoxin Snacks Group Ltd worth?
The market values Labixiaoxin Snacks Group Ltd at about HK$982M (market capitalisation, as of Nov 14, 2026). Per share that is HK$4.29; our models calculate a fair value of HK$1.22 per share.
What do the bullish and bearish scenarios say about 1262?
Our models span a range for Labixiaoxin Snacks Group Ltd: cautious scenario HK$0.9200, base HK$1.22, optimistic HK$1.53 per share (as of Nov 14, 2026, price HK$4.29). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Labixiaoxin Snacks Group Ltd (1262)?
Balance-sheet figures for Labixiaoxin Snacks Group Ltd (as of Nov 14, 2026): return on equity −3.2%. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is 1262 from its 52-week high?
Labixiaoxin Snacks Group Ltd trades at HK$4.29, about 7% below its 52-week high of HK$4.62 and 172% above the low of HK$1.58 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$1.22 is for.
Which stocks are comparable to Labixiaoxin Snacks Group Ltd?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Labixiaoxin Snacks Group Ltd stock attractive at the current price?
The data as of Nov 14, 2026: price HK$4.29, calculated fair value HK$1.22 (−72%), Quality Score 42/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 1262 calculated?
We run Labixiaoxin Snacks Group Ltd through 14 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of HK$1.22 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1% above its aggregate fair value. Labixiaoxin Snacks Group Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Labixiaoxin Snacks Group Ltd (1262)?
The closing price on Nov 13, 2026 was HK$4.29. Our model-based fair value is HK$1.22, about 72% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Labixiaoxin Snacks Group Ltd right now?
The price sits above even our optimistic bull case (HK$1.53). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Labixiaoxin Snacks Group Ltd

How large is the market capitalisation of Labixiaoxin Snacks Group Ltd (1262)?
The market capitalisation of Labixiaoxin Snacks Group Ltd is HK$982M (≈ $125M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Labixiaoxin Snacks Group Ltd (1262)?
The price-to-sales ratio of Labixiaoxin Snacks Group Ltd is 0.93 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Labixiaoxin Snacks Group Ltd (1262)?
The net margin of Labixiaoxin Snacks Group Ltd is −0.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Labixiaoxin Snacks Group Ltd (1262)?
The return on equity (ROE) of Labixiaoxin Snacks Group Ltd is −3.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Labixiaoxin Snacks Group Ltd (1262)?
On an EBIT basis the return on assets of Labixiaoxin Snacks Group Ltd is −3.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Labixiaoxin Snacks Group Ltd (1262)?
The operating margin of Labixiaoxin Snacks Group Ltd is −0.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Labixiaoxin Snacks Group Ltd (1262)?
Revenue at Labixiaoxin Snacks Group Ltd is growing 21.8% versus a year earlier (3y avg +12.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Labixiaoxin Snacks Group Ltd (1262) generate?
The free cash flow of Labixiaoxin Snacks Group Ltd is −50.6M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Labixiaoxin Snacks Group Ltd (1262) carry?
The net debt of Labixiaoxin Snacks Group Ltd is 448M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Labixiaoxin Snacks Group Ltd in the live analysis

One click puts Labixiaoxin Snacks Group Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.